AATI News

Stay up-to-date on the latest developments from Advanced Analytical Technologies, Inc., from new kits and publications to awards and new international offices.

Man reading newspaper

Advanced Analytical Technologies, Inc. (AATI) is Part of Rewriting CRISPR Workflow

Share on Facebook Share on LinkedIn Share on Twitter

Published: Wednesday, September 21st, 2016
Tags: CRISPR, Fragment Analyzer

AATI Application Scientist discusses heteroduplex cleavage assay for CRISPR in recent GEN Article

Large scale CRISPR workflows require efficient and accurate screening for successful editing events. Dr. Kyle Luttgeharm, Application Scientist at AATI, details the use of heteroduplex cleavage assays with the Fragment AnalyzerTM Automated CE System as a high throughput screening protocol in a recent gene therapy feature in GEN.

The article also discusses how CRISPR could provide vast improvements to gene therapy over previous methods and its impact on the treatment of several genetic diseases. This next generation gene editing strategy enables sophisticated modifications that will push gene therapy forward as an increasingly viable option for the treatment of genetic diseases.

Read the article in its entirety…

Advanced Analytical Technologies, Inc.
2450 SE Oak Tree Ct. Suite 101 Ankeny, IA 50021
(515) 964-8500

Related Articles

Top